In considering the clinical potential for VEGF therapy, it is important to determine whether growth of capillaries (angiogenesis) or of preexisting collaterals (arteriogenesis) is the therapeutic ...

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...